Population
110 unselected patients with aneurysmal subarachnoid haemorrhage from hospitals in a specified region in The…
Design
Cohort
Follow-up
3 months
Authors
Loading...
Poor outcomes in aneurysmal SAH driven mainly by initial bleed and rebleeding; leaves open whether delayed ischemia therapies meaningfully improve prognosis.
In patients with aneurysmal subarachnoid haemorrhage, poor outcomes are predominantly driven by the initial bleeding and rebleeding, suggesting that improving treatment for delayed ischaemia may have limited impact on overall prognosis.
Y. B. W. E. M. Roos (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: